-
Past
-
02/03/2021 11:00 Europe/Brussels
Numerous clinical trials with Ga-PSMA PET/CT have demonstrated that this procedure outperforms current standard imaging for both specificity and sensitivity. It is used to detect sites of prostate cancer allowing complete evaluation of the local tumor and lymph nodes, visceral and bone metastases with high accuracy in only one examination.
This webinar is already ready over. Missed the live webinar or want to rewatch it?
Speakers
Speakers
-
Prof Francisco AlvesChief Physicist & Head of CyclotronICNAS, University of Coimbra, Portugal -
Dr Jeremie CalaisDirector of the Clinical Research Program of the Nuclear Medicine and Theranostics DivisionUCLA, US -
Topics
-
68Ga Production process from a cyclotron: why & how?
-
Diagnostic efficacy of 68Ga-PSMA versus conventional imaging in prostate cancer patients.
-